Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$573.60 USD

573.60
1,438,184

+1.87 (0.33%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $573.31 -0.29 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for TMO

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Thermo Fisher Scientific Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 8,077 8,524 4,477 10,325 2,399
Receivables 8,221 8,115 7,977 5,741 4,349
Notes Receivable 0 0 0 0 0
Inventories 5,088 5,634 5,051 4,029 3,370
Other Current Assets 3,203 2,956 2,608 1,862 1,775
Total Current Assets 24,589 25,229 20,113 21,957 11,893
Net Property & Equipment 9,448 9,280 8,333 5,912 4,749
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 60,690 58,638 62,037 38,726 39,728
Deposits & Other Assets 3,999 4,007 4,640 2,457 2,011
Total Assets 98,726 97,154 95,123 69,052 58,381
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 3,609 5,579 2,537 2,628 676
Accounts Payable 2,872 3,381 2,867 2,175 1,920
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 4,842 5,449 5,377 4,230 2,685
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 2,689 2,601 2,655 1,271 916
Total Current Liabilities 14,012 17,010 13,436 10,304 6,197
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1,922 2,849 3,837 1,794 2,192
Convertible Debt 0 0 0 0 0
Long-Term Debt 31,308 28,909 32,333 19,107 17,076
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 4,642 4,238 4,540 3,340 3,241
Minority Interest (Liabilities) 118 116 122 0 0
Total Liabilities 52,002 53,122 54,268 34,545 28,706
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 442 441 439 437 434
Capital Surplus 17,286 16,743 16,174 15,579 15,064
Retained Earnings 47,364 41,910 35,431 28,116 22,092
Other Equity -3,235 -3,045 -2,267 -2,807 -2,679
Treasury Stock 15,133 12,017 8,922 6,818 5,236
Total Shareholder's Equity 46,724 44,032 40,855 34,507 29,675
Total Liabilities & Shareholder's Equity 98,726 97,154 95,123 69,052 58,381
Total Common Equity 46,724 44,032 40,855 34,507 29,675
Shares Outstanding 386.30 392.20 394.00 396.30 400.90
Book Value Per Share 120.95 112.27 103.69 87.07 74.02

Fiscal Year End for Thermo Fisher Scientific Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 8,077 6,151 3,133 3,482
Receivables NA 8,221 8,370 8,019 7,922
Notes Receivable NA 0 0 0 0
Inventories NA 5,088 5,404 5,655 5,664
Other Current Assets NA 3,203 3,167 3,188 3,141
Total Current Assets NA 24,589 23,092 19,995 20,209
Net Property & Equipment NA 9,448 9,167 9,292 9,354
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 60,690 60,674 60,710 61,112
Deposits & Other Assets NA 3,999 4,124 4,108 3,983
Total Assets NA 98,726 97,057 94,105 94,658
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 3,609 4,795 4,814 6,122
Accounts Payable NA 2,872 2,508 2,423 2,798
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 4,842 4,308 4,285 4,302
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 2,689 2,547 2,590 2,662
Total Current Liabilities NA 14,012 14,158 14,112 15,884
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 1,922 2,620 2,842 2,976
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 31,308 30,489 29,194 29,135
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 4,326 4,042 4,230
Minority Interest (Liabilities) NA 118 118 113 123
Total Liabilities NA 52,002 51,711 50,303 52,348
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 442 442 441 441
Capital Surplus NA 17,286 17,165 17,030 16,889
Retained Earnings NA 47,364 45,869 44,289 43,064
Other Equity NA -3,235 -3,009 -2,874 -3,001
Treasury Stock NA 15,133 15,121 15,084 15,083
Total Shareholder's Equity NA 46,724 45,346 43,802 42,310
Total Liabilities & Shareholder's Equity NA 98,726 97,057 94,105 94,658
Total Common Equity 0 46,724 45,346 43,802 42,310
Shares Outstanding 381.30 386.30 386.30 385.90 385.70
Book Value Per Share 0.00 120.95 117.39 113.51 109.70